Report overview
Glaucoma is caused due to rise in the intraocular pressure, if persists may lead to permanent eye damage.This increased pressure damages the optic nerve which transmits message to the brain High pressure is built due to the blockage of the trabecular meshwork which results in the accumulation of aqueous humor. Depending on the size of trabecular meshwork blockage, glaucoma can be categorized as open angle and narrow closure glaucoma. In open angle glaucoma trabecular meshwork blockage is wider than narrow angle glaucoma. This disease results in various symptoms such as redness in eye, nausea, vomiting, narrowing in vision and pain. This disease can be diagnosed by measuring eye pressure through tonometry.
This report aims to provide a comprehensive presentation of the global market for Glaucoma Pharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glaucoma Pharmaceuticals. This report contains market size and forecasts of Glaucoma Pharmaceuticals in global, including the following market information:
Global Glaucoma Pharmaceuticals Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Glaucoma Pharmaceuticals Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Glaucoma Pharmaceuticals companies in 2022 (%)
The global Glaucoma Pharmaceuticals market was valued at US$ 3349.7 million in 2022 and is projected to reach US$ 3750.6 million by 2029, at a CAGR of 1.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Key growth drivers of the market include rising ageing population, healthcare expenditures, medical coverage and new innovative combination drugs. The market players in medication as well as devices segments are totally different and somewhat very fragmented.
We surveyed the Glaucoma Pharmaceuticals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glaucoma Pharmaceuticals Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Pharmaceuticals Market Segment Percentages, by Type, 2022 (%)
Prostaglandins Analogues (PGAs)
Non PGAs
Global Glaucoma Pharmaceuticals Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Pharmaceuticals Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Private Clinics
Drug Stores
Retail Pharmacies
E-Commerce
Global Glaucoma Pharmaceuticals Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Glaucoma Pharmaceuticals Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glaucoma Pharmaceuticals revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Glaucoma Pharmaceuticals revenues share in global market, 2022 (%)
Key companies Glaucoma Pharmaceuticals sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Glaucoma Pharmaceuticals sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Acadia Pharmaceuticals Inc.
Allergan Inc.
Inotek Pharmaceuticals Corporation
Merck & Co. Inc.
Santen Pharmaceutical Co.Ltd.
Novartis International AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glaucoma Pharmaceuticals, market overview.
Chapter 2: Global Glaucoma Pharmaceuticals market size in revenue and volume.
Chapter 3: Detailed analysis of Glaucoma Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glaucoma Pharmaceuticals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glaucoma Pharmaceuticals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
